TriVascular, Inc.
TriVascular, Inc., a prominent player in the medical device industry, is headquartered in the United States. Founded in 2007, the company has established itself as a leader in innovative vascular solutions, particularly in the treatment of abdominal aortic aneurysms (AAAs). TriVascular's flagship product, the Ovation® Abdominal Stent Graft System, is renowned for its unique design that enhances patient outcomes through a minimally invasive approach. With a strong presence in North America and expanding operations in Europe, TriVascular is committed to advancing vascular health. The company has achieved significant milestones, including regulatory approvals and successful clinical trials, solidifying its market position. TriVascular continues to focus on developing cutting-edge technologies that address the evolving needs of healthcare professionals and patients alike.
DitchCarbon Score
How does TriVascular, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TriVascular, Inc.'s score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
TriVascular, Inc.'s reported carbon emissions
TriVascular, Inc., headquartered in the US, currently does not have specific carbon emissions data available, as indicated by the absence of reported figures. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reduce greenhouse gas emissions at this time. It is important to note that TriVascular, Inc. is a current subsidiary and may inherit emissions data and climate initiatives from its parent organisation. However, no specific details regarding such data or initiatives have been provided. As the company navigates its climate strategy, it may benefit from aligning with industry standards and frameworks, such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP), to enhance its sustainability efforts and transparency in emissions reporting.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TriVascular, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
